574 related articles for article (PubMed ID: 25470355)
41. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis.
Verit FF; Geyikli I; Yazgan P; Celik A
Arch Gynecol Obstet; 2006 Jun; 274(3):133-7. PubMed ID: 16532321
[TBL] [Abstract][Full Text] [Related]
42. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
Papakitsou EF; Margioris AN; Dretakis KE; Trovas G; Zoras U; Lyritis G; Dretakis EK; Stergiopoulos K
Maturitas; 2004 Mar; 47(3):185-93. PubMed ID: 15036488
[TBL] [Abstract][Full Text] [Related]
43. Association of pioglitazone treatment with decreased bone mineral density in obese premenopausal patients with polycystic ovary syndrome: a randomized, placebo-controlled trial.
Glintborg D; Andersen M; Hagen C; Heickendorff L; Hermann AP
J Clin Endocrinol Metab; 2008 May; 93(5):1696-701. PubMed ID: 18285411
[TBL] [Abstract][Full Text] [Related]
44. Association of metabolic syndrome parameters with TT3 and FT3/FT4 ratio in obese Turkish population.
Tarcin O; Abanonu GB; Yazici D; Tarcin O
Metab Syndr Relat Disord; 2012 Apr; 10(2):137-42. PubMed ID: 22229843
[TBL] [Abstract][Full Text] [Related]
45. Lumbar spine bone mineral density changes in patients with primary hyperparathyroidism according to age and gender.
Lumachi F; Camozzi V; Ermani M; Nardi A; Luisetto G
Ann N Y Acad Sci; 2007 Nov; 1117():362-6. PubMed ID: 17656570
[TBL] [Abstract][Full Text] [Related]
46. Relationship between serum adiponectin and bone mineral density in male patients with obstructive sleep apnea syndrome.
Chen DD; Huang JF; Lin QC; Chen GP; Zhao JM
Sleep Breath; 2017 May; 21(2):557-564. PubMed ID: 28341925
[TBL] [Abstract][Full Text] [Related]
47. Pattern of bone mineral density in patients with sporadic idiopathic hypoparathyroidism.
Laway BA; Goswami R; Singh N; Gupta N; Seith A
Clin Endocrinol (Oxf); 2006 Apr; 64(4):405-9. PubMed ID: 16584512
[TBL] [Abstract][Full Text] [Related]
48. Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women.
Trento LK; Pietropolli A; Ticconi C; Gravotta E; De Martino MU; Fabbri A; Piccione E
J Obstet Gynaecol Res; 2009 Feb; 35(1):152-9. PubMed ID: 19215563
[TBL] [Abstract][Full Text] [Related]
49. Skeletal effects of cyclic recombinant human growth hormone and salmon calcitonin in osteopenic postmenopausal women.
Holloway L; Kohlmeier L; Kent K; Marcus R
J Clin Endocrinol Metab; 1997 Apr; 82(4):1111-7. PubMed ID: 9100582
[TBL] [Abstract][Full Text] [Related]
50. Type I collagen racemization and isomerization and the risk of fracture in postmenopausal women: the OFELY prospective study.
Garnero P; Cloos P; Sornay-Rendu E; Qvist P; Delmas PD
J Bone Miner Res; 2002 May; 17(5):826-33. PubMed ID: 12009013
[TBL] [Abstract][Full Text] [Related]
51. Growth hormone favorably affects bone turnover and bone mineral density in patients with short bowel syndrome undergoing intestinal rehabilitation.
Tangpricha V; Luo M; Fernández-Estívariz C; Gu LH; Bazargan N; Klapproth JM; Sitaraman SV; Galloway JR; Leader LM; Ziegler TR
JPEN J Parenter Enteral Nutr; 2006; 30(6):480-6. PubMed ID: 17047171
[TBL] [Abstract][Full Text] [Related]
52. [Bone density and laboratory parameters of bone metabolism in patients with terminal heart disease].
Christ E; Linka A; Junga G; Odermatt M; Steinert H; Kiowski W; Schmid C
Schweiz Med Wochenschr; 1996 Sep; 126(37):1553-9. PubMed ID: 8927958
[TBL] [Abstract][Full Text] [Related]
53. Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years.
Jolly EE; Bjarnason NH; Neven P; Plouffe L; Johnston CC; Watts SD; Arnaud CD; Mason TM; Crans G; Akers R; Draper MW
Menopause; 2003; 10(4):337-44. PubMed ID: 12851517
[TBL] [Abstract][Full Text] [Related]
54. Role of vitamin D and parathyroid hormone in the regulation of bone turnover and bone mass in men: the MINOS study.
Szulc P; Munoz F; Marchand F; Chapuy MC; Delmas PD
Calcif Tissue Int; 2003 Dec; 73(6):520-30. PubMed ID: 12958693
[TBL] [Abstract][Full Text] [Related]
55. Effects of atorvastatin on bone mineral density (BMD) and bone metabolism in elderly males with osteopenia and mild dyslipidemia: a 1-year randomized trial.
Chen ZG; Cai HJ; Jin X; Lu JH; Wang J; Fang NY
Arch Gerontol Geriatr; 2014; 59(3):515-21. PubMed ID: 25131773
[TBL] [Abstract][Full Text] [Related]
56. Association between bone mineral density and metabolic syndrome in Turkish women who were postmenopausal.
Ozelci R; Dilbaz B; Ozkaya E; Cirik DA; Zengin T; Mollamahmutoğlu L
Int J Gynaecol Obstet; 2016 Jun; 133(3):370-4. PubMed ID: 26868072
[TBL] [Abstract][Full Text] [Related]
57. Bone Mineral Density in Relation to Metabolic Syndrome Components in Postmenopausal Women With Diabetes Mellitus Type 2.
Bilić-Ćurčić I; Makarović S; Mihaljević I; Franceschi M; Jukić T
Acta Clin Croat; 2017 Mar; 56(1):58-63. PubMed ID: 29120134
[TBL] [Abstract][Full Text] [Related]
58. Effect of epidural steroid injection on bone mineral density and markers of bone turnover in postmenopausal women.
Al-Shoha A; Rao DS; Schilling J; Peterson E; Mandel S
Spine (Phila Pa 1976); 2012 Dec; 37(25):E1567-71. PubMed ID: 23196966
[TBL] [Abstract][Full Text] [Related]
59. Bone Turnover Markers and Bone Mineral Density to Predict Osteoporotic Fractures in Older Women: A Retrospective Comparative Study.
Qu XL; Zheng B; Chen TY; Cao ZR; Qu B; Jiang T
Orthop Surg; 2020 Feb; 12(1):116-123. PubMed ID: 31880071
[TBL] [Abstract][Full Text] [Related]
60. The relation of body mass index, menopausal symptoms, and lipid profile with bone mineral density in postmenopausal women.
Alay I; Kaya C; Cengiz H; Yildiz S; Ekin M; Yasar L
Taiwan J Obstet Gynecol; 2020 Jan; 59(1):61-66. PubMed ID: 32039802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
